Stage III colon cancer study

Full Name

Colon Cancer (CALGB-C80702): A phase III trial of 6 versus 12 treatments of adjuvant FOLFOX plus celecoxib or placebo for patients with resected stage III colon cancer (version date 9/9/10 and consent 9/9/10) (1_PRO00000601 - CIRB)

Eligibility

Inclusion Criteria

o Greater than 18 years of age
o Male, Female regardless of race
o Histological documented Adenocarcinoma of the Colon.
o Cancer/tumor must be completely resected
o Must have at least one pathological lymph node
o Participant cannot have residual nodal disease or metastatic disease.
o Must have the appropriate ECOG performance status and lab values